Joint Statement on transparency and data integrity

ICMRA and the World Health Organization (WHO) are urging pharmaceutical companies to publish clinical trial reports for new medicines and vaccines without redactions to ensure that research results are publicly accessible to all those involved in health care decision-making. In a joint statement, they stress that systematic transparency can increase trust in regulatory decision-making, reassure the public about data integrity and can stimulate research and development, which could have a positive impact on vaccine confidence.

Joint Statement on transparency and data integrity (7 May 2021) [PDF]

 

Statement in other languages